ERCC1 and colorectal carcinoma: Sebio et al. (European ancestry; Spain) reported a significant association of the ERCC1 rs11615 SNP with response to neoadjuvant capecitabine/RT (p = 0.023) in 84 patients with CRC (stages II–III) [24].